Key facts
- It has raised $113.6M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Techstars, Hub71, Mohammed Bin Rashid Innovation Fund, Cedar Mundi Ventures, Knuru Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Klaim
- ·The full record, as it builds
Funding rounds
No funding rounds for Klaim are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Klaim
Developer of a healthcare claim payment acceleration platform designed for improving cash flow efficiency. The company's platform facilitates rapid reimbursement processing by purchasing submitted claims and disbursing payments, eliminating delays associated with traditional insurance settlements, enabling healthcare providers to stabilize revenue cycles, reduce administrative burdens, and enhance operational liquidity without requiring loans or credit assessments.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 49
- Website
- klaim.com/
- Ownership
- Privately Held (backing)
Klaim doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Klaim shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Klaim in its N-PORT filings yet. We sweep new filings monthly.